SMEs: their need for strategic information
- challenges and opportunities for SMEs
within the life science cluster
Hans M Borchgrevink MD MHA
Senior adviser
The Research Council of Norway
The Research Council of Norway
Director General
Staff
International staff
Administration
Division for
Science
Communication
Division for
Strategic
Priorities
Division for
Innovation
Division for Science
Social Sciences
Humanities
Division director
Staff
Physical Sciences and Technology
Biology and Biomedicine
Clinical Medicine and Public Health
Division for Strategic Priorities
Future Technologies
Division Director
Staff
Society and Public Policy
Environmental Issues, Energy
and Sustainable Development
Marine Resources
and Environment
Division for Innovation
Promotion of R&D
and Commercialisation
Manufacturing, ICT and Services
Division Director
Staff
Biotechnology, Food Science
and Tax Incentive Schemes
Agricultural and Marine Research
Energy, Petroleum
and Maritime Research
Total budget by divisions mill. NOK (2004)
misc.adm.
118
Division for
Science
204
Division for
Innovation
1579
1535
1076
Total NOK 4 616 million
(administration incl.)
Division for
Strategic
Priorities
Total budget by activities
Infrastructure
(2004)
Miscellaneous
Programmes
Independent
projects
Total NOK 4 616 million
(administration incl.)
Funding from the ministries (2004)
Administration
The Research Fund
606
Miscellaneous
ministries
Ministry of Education
and Research
204
1 291
Ministry of
Environment
Ministry of
Agriculture
Ministry of
Fisheries
130
Ministry
of Trade and
Industry
215
324
236
288
861
Total NOK 4 616 million
(administration incl.)
Ministry of
Petroleum
and energy
Budget development
4500
4000
3500
3000
2500
2000
1500
1000
500
0
1993
(1993-2004)
Mill. NOK
1993-NOK
1995
1997
1999
2001
2003
R&D expenses in Norway
versus
RCN budget (bill.NOK)
30
25
20
15
10
5
0
1993
1995
1997
Totale FoU-utgifter i Norge
Kilde: Indikatorrapporten, Norges forskningsråd
1999
2001
2003
Forskningsrådets budsjett
1Prognoser for FoU-utgifter i 2003
R&D expenses in % of GNP for the Nordic
countries compared with OECD mean
4,5
Sweden
4
Finland
Iceland
3,5
3
2,5
Denmark
OECD-snitt
2
Norway
1,5
1
0,5
1981
1991
2001
The relation between GNP and R&D
expenses 1991-2003 for Norway
30
1600
25
BNP, mrd. kroner
1400
1200
20
1000
15
800
600
10
400
5
200
0
FoU-utgifter, mrd. kroner
1800
0
1991
1993
1995
BNP
Kilde: Indikatorrapporten
1997
1999
2001
2003
Totale FoU-utgifter
1Prognoser for FoU-utgifter i 2003
R&D expenses (2001) for OECD countries
in NOK per inhabitant and in % of GNP
NOK per innbygger
12 000
OECD-gjennomsnitt 2,33 prosent
Sverige
10 000
USA
Island
8 000
Canada
6 000
Norge
Østerrike
Storbritannia
4 000
Sveits
Japan
Danmark
Tyskland
Frankrike
OECD-gjennomsnitt 5 200 NOK
Nederland
Belgia
Korea
EU
Irland
Italia
Spania
Portugal
2 000
Finland
0
0,0
0,5
1,0
1,5
2,0
2,5
Prosent av BNP
3,0
3,5
4,0
4,5
Kilde: OECD – Main Science and Technology Indicators 2003:1, nasjonal FoU-statistikk for Danmark
Governmental R&D expenses (2001) for OECD
countries – in NOK per inhabitant and in % of GNP
NOK per innbygger
3000
OECD-gjennomsnitt 0,67 prosent
2500
USA
Norge
Danmark
2000
Sveits
Canada
OECD-gjennomsnitt 1 502 NOK
1500
Island
Tyskland
Nederland
Sverige
Finland
Frankrike
Japan
1000
Spania
500
Østerrike
Portugal
Irland
0
0,0
0,2
0,4
0,6
0,8
1,0
1,2
Prosent av BNP
Kilde: OECD – Main Science and Technology Indicators 2003:1, nasjonal FoU-statistikk for Danmark
% annual growth in R&D expenses
1995-2001 for the Nordic, USA, OECD
20
N orge
15
O ECD gjennomsnitt
U SA
Sverige
10
5
0
Danmark
Finland
R&D in private enterprises
Sweden
Finland
Japan
USA
Iceland
Germany
Denmark
Belgium
Luxembourg
France
EU15
UK
Austria
Netherlands
Norway
Irland
Italy
Spain
0,0 %
1,0 %
2,0 %
% of GNP 2001
3,0 %
Nordic innovative enterprises in % of total
number of enterprises (2001)
45
40
35
30
25
20
15
Norge
Sverige
Finland
Danmark
10
5
0
2001
New/improved products as % of
total turnover (2000; Norway 2001)
Norway
France
Finland
Austria
Germany
%
0
10
20
30
40
High- and medium-tech exports in %
of total industrial exports (2001)
High-tech
Iceland
Norway
Medium-tech
Denmark
Finland
Sweden
USA
Irland
%
Japan
0
20
40
60
80
R&D investments by private
enterprises in % of GNP
6
%
Sweden
5
4
Finland
3
Denmark
2
OECD-mean
Norway
1
1995
1997
1999
2001
Nordic scientific papers in international
journals - per 100.000 inhabitants
Sweden
1,7
Finland
Iceland
Denmark
Norway
1,5
1,3
1,1
0,9
0,7
0,5
1990
1992
1994
1996
1998
2000
2002
Scientific publications from Norway with and
without international co-author 1983-2002
3000
2500
2000
1500
1000
500
0
-83 -84 -85 -86 -87 -88 -89 -90 -91 -92 -93 -94 -95 -96 -97 -98 -99 -00 -01 -02
Uten internasjonalt samarbeid
Med internasjonalt samarbeid
Kilde: Science Citation Index
Scientific publications co-authored by Norwegian
researchers by countries of collaboration
1200
1000
EU except the
Nordic
800
North-America
600
The Nordic
400
Other countries
200
Former Eastern
Europe
0
81 9 84
9
1
1
87 9 90 9 93 9 96
9
1
1
1
1
99 0 02
9
1
2
Kilde: Science Citation Index
Nordic Science Citation Index
1,4
Denmark
1,3
1,2
1,1
1
Sweden
Finland
World mean=1
Norway
0,9
0,8
1981
1986
1991
1996
2001
SMEs go LifeSciences 1
FP6 SSA (Specific Support Action)
Programme: Research and innovation
ETI (Economic and Technological Intelligence)
HRM i 6RP
FP6 (EC PART): THREE MAIN BLOCKS OF ACTIVITIES
BLOCK 2: STRUCTURING THE ERA
Research and
Innovation
Human
resources &
mobility
Research
infrastructures
Science and
society
Research for
policy support
Citizens and governance
Sustainable development, global
change and ecosystems
Food quality and safety
Aeronautics and Space
Nanotech
Information society tech
Genomics and biotech.
BLOCK 1: FOCUSING AND INTEGRATING EUROPEAN RESEARCH
ANTICIPATING S/T NEEDS
7 PRIORITY THEMATIC AREAS
New and emerging
science and
technologies
Specific SME activities
Specific international co-operation
activities
JRC activities
BLOCK 3: STRENGTHENING THE
FOUNDATIONS OF ERA
Co-ordination of
research activities
Development of research/innovation
policies
SMEs go LifeSciences 2
Objective: to support and foster the participatioin of
SMEs and SME groupings in Life Sciences projects of
the EU FP6, particularly in
- IPs (Integrated Programmes)
- NoE (Networks of Excellence)
- STREPS (Specific targeted research projects)
Goal: SMEs should have 15% of budgets in FP6
LifeSciences (now only 8%)
SMEs go LifeSciences 3
18 mill. SMEs in Europe
95% of European enterprises are SMEs
SMEs contribute to appr. 2/3 of employment and
economic turnover in Europe
However,
Only 4% of EoI submitters to FP6 LifeSciences
were from industry incl SMEs
Targeted, tailored support for SMEs is needed
SMEs go LifeSciences 4
28 partners from 26 countries
- 12 members states
- 10 candidate countries
- 4 associated states (incl Switzerland)
Main activities:
Capacity building and training
- for SMEs and SME groupings
- for researchers on how to involve SMEs
Consortium building and match-making
for SMEs and researchers preparing proposals
SMEs go LifeSciences 5
Activities:
Promote transregional co-operation between SMEs
Stimulate networks of Life Sciences incubators and
biovalleys
Facilitate the creation of co-operations and groupings
of SMEs with similar innovation needs
SMEs go LifeSciences 6
To support and foster the participatioin of SMEs and
SME groupings in Life Sciences projects of the EU FP6
within the relevant Thematic Priorities (TPs), i.e.
- TP 1 Life Sciences, Genomics and Biotechnologies
and in relevant parts of
- TP 2 IST – e.g. bioinformatics
- TP 3 Nanotechnologies
- TP 5 Food quality and safety
(11 partners also participates in the complementary ETI
”SMEsforFOOD”
SMEs go LifeSciences 7
SMEs will receive direct support, assistance and
coaching for successful participation in FP6
Increasing visibility and Match-making will be made
through preparation of
- SME (activity) profile forms
- FP6 profile forms
for electronic storage in catalogues for partner search
also in search for partners to enter ongoing projects
Seminars - trans-national, and with national followups - will be organised on SME-relevant topics (e.g.
IPR)
for dissemination of information for SME coaching
SMEs go LifeSciences 8
Outcome envisaged: The project aims to
- contact 2500 SMEs and SME groupings
- enter 250 high-quality SME profiles into the database
- contact 400 FP6 researchers/coordinators
- enter 100 researcher/coordinator/proposal/project
profiles into the database
- make 300 consortiae take in at least one additional
SME partner
- and thereby contribute to the creation of the European
research Area (ERA)
SMEs go LifeSciences 9
The project will recruit SMEs by visiting universities
and research parks/ incubators/ biovalleys
The international kick-off meeting was held in
Warsaw late March 2004
The Norwegian project is run by the RCN, had kickoff late March 2004 and includes
- a part-time project manager (HM Borchgrevink)
- a steering group (RCN representatives)
- a reference group (universities/incubators/innovation/biotech organisation)
SMEs go LifeSciences 10
We want to run the project in close contact with
- the Norwegian universities, research parks, incubators,
innovation units and biotech organisations
- other Nordic networking activities in the field of Life
Sciences (e.g. MedCoast, ScanBalt, MediconValley,
STRATINC)
which is in line with the recent Nordic political
initiatives to promote a Nordic Research & Innovation
Area (NORIA) to obtain synergy and ”critical mass”